159 related articles for article (PubMed ID: 36086802)
1. Small ubiquitin-related modifier (SUMO)ylation of SIRT1 mediates (-)-epicatechin inhibited- differentiation of cardiac fibroblasts into myofibroblasts.
Luo Y; Lu J; Wang Z; Wang L; Wu G; Guo Y; Dong Z
Pharm Biol; 2022 Dec; 60(1):1762-1770. PubMed ID: 36086802
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway.
Dong ZX; Wan L; Wang RJ; Shi YQ; Liu GZ; Zheng SJ; Hou HL; Han W; Hai X
Cell Physiol Biochem; 2017; 41(5):2004-2015. PubMed ID: 28420000
[TBL] [Abstract][Full Text] [Related]
3. Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.
Ma ZG; Yuan YP; Zhang X; Xu SC; Wang SS; Tang QZ
EBioMedicine; 2017 Apr; 18():179-187. PubMed ID: 28330809
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
Cui Y; Wang Y; Liu G
Pharm Biol; 2021 Dec; 59(1):1305-1313. PubMed ID: 34607503
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epicatechin induces physiological cardiac growth by activation of the PI3K/Akt pathway in mice.
De Los Santos S; García-Pérez V; Hernández-Reséndiz S; Palma-Flores C; González-Gutiérrez CJ; Zazueta C; Canto P; Coral-Vázquez RM
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27605464
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Reduces Cardiac Interstitial Fibrosis by Inhibiting Erk1/2-Serpine2 and P-Akt Signalling Pathways.
Li X; Wang G; QiLi M; Liang H; Li T; E X; Feng Y; Zhang Y; Liu X; Qian M; Xu B; Shen Z; Gitau SC; Zhao D; Shan H
Cell Physiol Biochem; 2018; 45(5):1955-1965. PubMed ID: 29518782
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy.
Liu MY; Yue LJ; Luo YC; Lu J; Wu GD; Sheng SQ; Shi YQ; Dong ZX
Eur J Pharmacol; 2022 Sep; 930():175155. PubMed ID: 35863508
[TBL] [Abstract][Full Text] [Related]
8. (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.
Li JW; Wang XY; Zhang X; Gao L; Wang LF; Yin XH
Mol Med Rep; 2018 Jun; 17(6):8300-8308. PubMed ID: 29658565
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
10. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
11. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q
Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662
[TBL] [Abstract][Full Text] [Related]
13. Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
Miteva K; Van Linthout S; Pappritz K; Müller I; Spillmann F; Haag M; Stachelscheid H; Ringe J; Sittinger M; Tschöpe C
Stem Cells Transl Med; 2016 Dec; 5(12):1707-1718. PubMed ID: 27460853
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
15. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
Ma ZG; Zhang X; Yuan YP; Jin YG; Li N; Kong CY; Song P; Tang QZ
Clin Sci (Lond); 2018 Mar; 132(6):685-699. PubMed ID: 29540538
[TBL] [Abstract][Full Text] [Related]
16. Belumosudil, ROCK2-specific inhibitor, alleviates cardiac fibrosis by inhibiting cardiac fibroblasts activation.
Liu Q; Li HY; Wang SJ; Huang SQ; Yue Y; Maihemuti A; Zhang Y; Huang L; Luo L; Feng KN; Wu ZK
Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H235-H247. PubMed ID: 35657612
[TBL] [Abstract][Full Text] [Related]
17. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro.
Xiao J; Sheng X; Zhang X; Guo M; Ji X
Drug Des Devel Ther; 2016; 10():1267-77. PubMed ID: 27099472
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts.
Bai J; Zhang N; Hua Y; Wang B; Ling L; Ferro A; Xu B
PLoS One; 2013; 8(9):e72120. PubMed ID: 24023727
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition.
Okayama K; Azuma J; Dosaka N; Iekushi K; Sanada F; Kusunoki H; Iwabayashi M; Rakugi H; Taniyama Y; Morishita R
Hypertension; 2012 May; 59(5):958-65. PubMed ID: 22392903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
